NM_000209.4:c.226G>A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000209.4(PDX1):​c.226G>A​(p.Asp76Asn) variant causes a missense change. The variant allele was found at a frequency of 0.00489 in 1,545,430 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0032 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0051 ( 23 hom. )

Consequence

PDX1
NM_000209.4 missense

Scores

1
6
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:13

Conservation

PhyloP100: 6.18
Variant links:
Genes affected
PDX1 (HGNC:6107): (pancreatic and duodenal homeobox 1) The protein encoded by this gene is a transcriptional activator of several genes, including insulin, somatostatin, glucokinase, islet amyloid polypeptide, and glucose transporter type 2. The encoded nuclear protein is involved in the early development of the pancreas and plays a major role in glucose-dependent regulation of insulin gene expression. Defects in this gene are a cause of pancreatic agenesis, which can lead to early-onset insulin-dependent diabetes mellitus (IDDM), as well as maturity onset diabetes of the young type 4 (MODY4). [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005629629).
BP6
Variant 13-27920364-G-A is Benign according to our data. Variant chr13-27920364-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 8859.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-27920364-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00319 (486/152124) while in subpopulation NFE AF= 0.00489 (332/67962). AF 95% confidence interval is 0.00445. There are 3 homozygotes in gnomad4. There are 189 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDX1NM_000209.4 linkc.226G>A p.Asp76Asn missense_variant Exon 1 of 2 ENST00000381033.5 NP_000200.1 P52945

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDX1ENST00000381033.5 linkc.226G>A p.Asp76Asn missense_variant Exon 1 of 2 1 NM_000209.4 ENSP00000370421.4 P52945

Frequencies

GnomAD3 genomes
AF:
0.00320
AC:
487
AN:
152016
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00116
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00432
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00373
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00488
Gnomad OTH
AF:
0.00478
GnomAD3 exomes
AF:
0.00288
AC:
416
AN:
144486
Hom.:
2
AF XY:
0.00308
AC XY:
240
AN XY:
78048
show subpopulations
Gnomad AFR exome
AF:
0.00105
Gnomad AMR exome
AF:
0.00220
Gnomad ASJ exome
AF:
0.00244
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00182
Gnomad FIN exome
AF:
0.000608
Gnomad NFE exome
AF:
0.00516
Gnomad OTH exome
AF:
0.00263
GnomAD4 exome
AF:
0.00507
AC:
7064
AN:
1393306
Hom.:
23
Cov.:
33
AF XY:
0.00490
AC XY:
3363
AN XY:
686990
show subpopulations
Gnomad4 AFR exome
AF:
0.000985
Gnomad4 AMR exome
AF:
0.00309
Gnomad4 ASJ exome
AF:
0.00239
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00209
Gnomad4 FIN exome
AF:
0.000693
Gnomad4 NFE exome
AF:
0.00593
Gnomad4 OTH exome
AF:
0.00473
GnomAD4 genome
AF:
0.00319
AC:
486
AN:
152124
Hom.:
3
Cov.:
33
AF XY:
0.00254
AC XY:
189
AN XY:
74364
show subpopulations
Gnomad4 AFR
AF:
0.00116
Gnomad4 AMR
AF:
0.00425
Gnomad4 ASJ
AF:
0.00259
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00373
Gnomad4 FIN
AF:
0.000283
Gnomad4 NFE
AF:
0.00489
Gnomad4 OTH
AF:
0.00473
Alfa
AF:
0.00331
Hom.:
1
Bravo
AF:
0.00399
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.000291
AC:
1
ESP6500EA
AF:
0.00317
AC:
22
ExAC
AF:
0.00110
AC:
93
Asia WGS
AF:
0.000578
AC:
2
AN:
3476

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:13
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:5
Mar 11, 2024
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 09, 2021
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The p.Asp76Asn variant in the PDX1 gene has been classified as benign because it has been identified in 0.49% (336/68440) of Northern European chromosomes, including 2 homozygotes, by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BA1. -

Jan 08, 2020
Genetic Services Laboratory, University of Chicago
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 12, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: PDX1 c.226G>A (p.Asp76Asn) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0029 in 144486 control chromosomes in the gnomAD database, including 2 homozygotes. The observed variant frequency is approximately 2303 fold of the estimated maximal expected allele frequency for a pathogenic variant in PDX1 causing Familial Monogenic Diabetes (Maturity Onset Diabetes Of The Young 4)/Neonatal Diabetes Mellitus phenotype (1.3e-06), strongly suggesting that the variant is benign. The following publications have been ascertained in the context of this evaluation (PMID: 10545531, 10720084, 10545530, 15170499). ClinVar contains an entry for this variant (Variation ID: 8859). Based on the evidence outlined above, the variant was classified as likely benign. -

Maturity onset diabetes mellitus in young Pathogenic:1Benign:2
Jun 22, 2022
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Dec 10, 2023
Genomic Research Center, Shahid Beheshti University of Medical Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Dec 18, 2017
Biomedical Genomics and Oncogenetics Laboratory, Institut Pasteur de Tunis, University Tunis El Manar
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: research

- -

not provided Benign:3
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 02, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 20, 2021
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 28323911, 15170499, 15277425, 19515026, 10720084, 24097065, 10545531, 10545530, 26669242) -

Diabetes mellitus type 2, susceptibility to Uncertain:1
Nov 01, 1999
OMIM
Significance: Uncertain significance
Review Status: flagged submission
Collection Method: literature only

- -

Type 2 diabetes mellitus Benign:1
Dec 10, 2023
Genomic Research Center, Shahid Beheshti University of Medical Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Monogenic diabetes Benign:1
Oct 12, 2018
Personalized Diabetes Medicine Program, University of Maryland School of Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: research

ACMG criteria: BS2 (cases=controls in PMID 17592437, 21569088), BS1 (0.4% MAF in gnomAD)= benign; REVEL 0.245 +BP4/4 predictors + PP3/6 predictors: conflicting evidence, not using) OMIM suggests that it is a susceptability factor for T2DM -

Maturity-onset diabetes of the young type 4 Benign:1
Jan 22, 2020
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: curation

The p.Asp76Asn variant in PDX1 (sometimes called IPF1) has been reported in at least 32 individuals with Maturity-Onset Diabetes of the Young (PMID: 15277425, 10545531, 10545530, 17592437), and has been identified in 0.4909% (336/68440) of European (non-Finnish) chromosomes, including 2 homozygotes, by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs137852783). Please note that for diseases with clinical variability, or reduced penetrance, pathogenic variants may be present at a low frequency in the general population. However, this variant does not segregate with disease in many families, including sibling pairs (PMID: 10545531, 15277425). This variant has also been reported as a benign variant, likely benign variant, VUS, likely pathogenic variant, and risk factor for diabetes in ClinVar (Variation ID: 8859). In vitro functional studies provide some evidence that the p.Asp76Asn variant may slightly impact protein function, but this evidence is not conclusive (PMID: 10545531). These types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, this variant meets criteria to be classified as benign for Maturity-Onset Diabetes of the Young in an autosomal dominant manner based on a higher than expected frequency in control cohorts and nonsegregation with MODY. ACMG/AMP Criteria applied: BS2, BS4, BP4 (Richards 2015). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.29
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.43
T
Eigen
Benign
0.12
Eigen_PC
Benign
0.17
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.72
T
M_CAP
Uncertain
0.22
D
MetaRNN
Benign
0.0056
T
MetaSVM
Uncertain
-0.039
T
MutationAssessor
Benign
1.8
L
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.24
Sift
Uncertain
0.0030
D
Sift4G
Benign
0.14
T
Polyphen
0.48
P
Vest4
0.43
MVP
0.87
MPC
1.1
ClinPred
0.019
T
GERP RS
4.1
Varity_R
0.15
gMVP
0.55

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs137852783; hg19: chr13-28494501; COSMIC: COSV105828488; COSMIC: COSV105828488; API